Diplomat Named a National Standard Among Michigan’s Top Workplaces
FLINT, Mich. – Dec. 8, 2016 – The nation’s largest independent specialty pharmacy has been awarded a 2016 Top Workplaces National Standard honor by the Detroit Free Press.
Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit Free Press as a 2016 Top Workplaces National Standard.
To learn more about Diplomat’s career opportunities, visit diplomat.is/careers.
Results are based on an employee survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational health and workplace improvement. The survey measures several aspects of workplace culture, including alignment, execution, and connection.
“We are honored to earn Top Workplaces recognition for the third consecutive year,” said Phil Hagerman, Diplomat CEO and chairman. “Here at Diplomat, we are committed to creating a healthy workplace by meeting the needs of our employees. We are proud that our employees recognize and echo that commitment through the survey results.”
Diplomat was also recently selected as one of Michigan’s Best and Brightest in Wellness for the fourth year in a row.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Kali Lucas, Public Relations Specialist
810.768.9580 | firstname.lastname@example.org
@Pharmacy_TimesRT @Pharmacy_Times: .@US_FDA Officials OK Tofacitinib for Active Psoriatic #Arthritis https://t.co/vE6PT5Vl6d1 day ago
@FDA_Drug_InfoRT @FDA_Drug_Info: FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-St…2 days ago
@SpecialtyPTimesRT @SpecialtyPTimes: PBM Acquisition Allows @DiplomatRx to Expand Patient-Centric Offerings https://t.co/ntV4kEsnvX4 days ago
@DiplomatRxDiplomat Adds Chris Luthin as Executive Vice President https://t.co/JI0e9UIBHe5 days ago
@DiplomatRxDon’t forget to register for @CBI_Conferences “Patient Journey Mapping—From Diagnosis to Treatment.” This event gat… https://t.co/czVklVOW6Z5 days ago